Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Debt to Equity (2019 - 2026)

Biodesix filings provide 8 years of Debt to Equity readings, the most recent being $5.09 for Q1 2026.

  • On a quarterly basis, Debt to Equity rose 53.44% to $5.09 in Q1 2026 year-over-year; TTM through Mar 2026 was $5.09, a 53.44% increase, with the full-year FY2025 number at -$19.25, down 1203.63% from a year prior.
  • Debt to Equity hit $5.09 in Q1 2026 for Biodesix, up from -$19.25 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $41.11 in Q2 2025 to a low of -$30.61 in Q3 2023.
  • Median Debt to Equity over the past 5 years was $1.72 (2022), compared with a mean of -$0.94.
  • The widest YoY moves for Debt to Equity: up 3479.33% in 2025, down 2210.43% in 2025.
  • Biodesix's Debt to Equity stood at $1.72 in 2022, then surged by 626.61% to $12.46 in 2023, then tumbled by 86.01% to $1.74 in 2024, then crashed by 1203.63% to -$19.25 in 2025, then skyrocketed by 126.45% to $5.09 in 2026.
  • The last three reported values for Debt to Equity were $5.09 (Q1 2026), -$19.25 (Q4 2025), and -$27.36 (Q3 2025) per Business Quant data.